Company / Capital Expenditures
Teladoc Health, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$8.9M
FY2025
5-year range
$8.5M / $16.5M
FY2021-FY2025
Trend
-17.6%
vs FY2024
Sector context
#112 of 145
Health Care
What the data says
Teladoc Health, Inc.'s capital expenditures of $9M is lower than 77% of companies in the Health Care sector (FY2025). Capital Expenditures has declined for 3 consecutive years, from $16M in FY2022 to $9M in FY2025.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of +17.2%.
Declined from $11M to $9M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -18.6%
- 5-Year CAGR
- +17.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 145This company $8.9M Sector average $268.6M
▼
-96.7% below sector average
Key checks
Key Insights
- Teladoc Health, Inc.'s capital expenditures has declined for 3 consecutive years.
- 5-year CAGR of +17.2%, indicating consistent growth.
- In FY2025, capital expenditures decreased 17.6% year-over-year.
- Ranks #112 out of 145 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.9M | -17.6% |
| FY2024 | $10.8M | -5.9% |
| FY2023 | $11.5M | -30.4% |
| FY2022 | $16.5M | +93.1% |
| FY2021 | $8.5M | +112.1% |
| FY2020 | $4.0M | +14.6% |
| FY2019 | $3.5M | -12.5% |
| FY2018 | $4.0M | +52.3% |
| FY2017 | $2.6M | +24.9% |
| FY2016 | $2.1M | -66.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026